Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baptist Gallwitz

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Journal of the International Neuropsychological Society : JINS|July 30, 2009
Younger age is a good predictor of better executive function after surgery for pituitary adenoma in adultsKarsten Müssig, Thomas Leyhe, Britta Besemer, et al.
European Journal of Gastroenterology & Hepatology|July 13, 2007
Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemiaKarsten Müssig, Stephan Petersenn, Manfred Wehrmann, et al.
Obesity (Silver Spring, Md.)|April 19, 2008
11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivityKarsten Müssig, Thomas Remer, Axel Haupt, et al.
Current Medical Research and Opinion|December 22, 2007
Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the PREDICTIVE studyAnne Dornhorst, Hans-Joachim Lüddeke, Marek Honka, et al.
Thyroid : Official Journal of the American Thyroid Association|August 24, 2007
A novel MR-imaging technique using arterial spin labeling for thyroid gland perfusion in thyrotoxicosisKarsten Müssig, Christina Schraml, Baptist Gallwitz, et al.
Psychoneuroendocrinology|September 30, 2008
Increased occurrence of weaknesses in attention testing in patients with Hashimoto's thyroiditis compared to patients with other thyroid illnessesThomas Leyhe, Karsten Müssig, Claudia Weinert, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetesJuris J Meier, Baptist Gallwitz, Stefan Salmen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 18, 2020
Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering MedicationsAndreas Fritsche, Martin Heni, Andreas Peter, et al.
Diabetes, Obesity & Metabolism|October 21, 2016
Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trialsFrancisco J Tinahones, Baptist Gallwitz, Matias Nordaby, et al.
Cardiovascular Diabetology|September 5, 2015
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide studyRafael Simó, Bruno Guerci, Guntram Schernthaner, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Journal of the International Neuropsychological Society : JINS|July 30, 2009
Younger age is a good predictor of better executive function after surgery for pituitary adenoma in adultsKarsten Müssig, Thomas Leyhe, Britta Besemer, et al.
European Journal of Gastroenterology & Hepatology|July 13, 2007
Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemiaKarsten Müssig, Stephan Petersenn, Manfred Wehrmann, et al.
Obesity (Silver Spring, Md.)|April 19, 2008
11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivityKarsten Müssig, Thomas Remer, Axel Haupt, et al.
Current Medical Research and Opinion|December 22, 2007
Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the PREDICTIVE studyAnne Dornhorst, Hans-Joachim Lüddeke, Marek Honka, et al.
Thyroid : Official Journal of the American Thyroid Association|August 24, 2007
A novel MR-imaging technique using arterial spin labeling for thyroid gland perfusion in thyrotoxicosisKarsten Müssig, Christina Schraml, Baptist Gallwitz, et al.
Psychoneuroendocrinology|September 30, 2008
Increased occurrence of weaknesses in attention testing in patients with Hashimoto's thyroiditis compared to patients with other thyroid illnessesThomas Leyhe, Karsten Müssig, Claudia Weinert, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetesJuris J Meier, Baptist Gallwitz, Stefan Salmen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 18, 2020
Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering MedicationsAndreas Fritsche, Martin Heni, Andreas Peter, et al.
Diabetes, Obesity & Metabolism|October 21, 2016
Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trialsFrancisco J Tinahones, Baptist Gallwitz, Matias Nordaby, et al.
Cardiovascular Diabetology|September 5, 2015
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide studyRafael Simó, Bruno Guerci, Guntram Schernthaner, et al.
Pageof 13